SQZB

0.02400.00%
MS

Marc Schegerin

Independent Director

Dr. Marc Schegerin, MD, MBA, is Chief Executive Officer of Talawar Tx Inc. Dr. Schegerin serves as an Independent Director of SQZ Biotechnologies Co. since October 2020. Dr. Schegerin serves as Chief Financial Officer and Chief Operating Officer at Morphic Holding, Inc. since April 2020. He served as the Chief Financial Officer at ArQule, Inc. since March 29, 2019. Dr. Schegerin served as Head of Strategy and Communications at ArQule, Inc. since 2019 and served as its Treasurer since 2019 until January 16, 2020. Dr. Schegerin served as Senior Vice President and Head of Strategy, Finance and Communication at ArQule, Inc. since May 2018 until March 29, 2019. Dr. Schegerin served as Vice President of Investment Banking of Bank of America Merrill Lynch from August 2014 to June 2016. Dr. Schegerin joins ArQule with extensive experience in the pharmaceutical industry and healthcare investment banking. Prior to ArQule, Dr. Schegerin was a Healthcare Investment Banking Director at Citigroup from June 2016 to April 2018. His prior experience includes Strategy and Development leadership roles at Sage Therapeutics and Biogen and he began his career at Goldman Sachs. Dr. Schegerin received an M.D. from Dartmouth Medical School and an M.B.A. from the Tuck School of Business at Dartmouth. Dr. Schegerin received a B.S. from Tulane University and undergraduate degrees in premedical studies from Harvard University.

Positions